Bosman F - Search Results

1

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

Helbling D, Bodoky G, Gautschi O, Sun H, Bosman F, Gloor B, Burkhard R, Winterhalder R, Madlung A, Rauch D, Saletti P, Widmer L, Borner M, Baertschi D, Yan P, Benhattar J, Leibundgut EO, Bougel S, Koeberle D. Helbling D, et al. Among authors: bosman f. Ann Oncol. 2013 Mar;24(3):718-25. doi: 10.1093/annonc/mds519. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139259 Free article. Clinical Trial.

2

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, Klingbiel D, Dietrich D, Biesmans B, Bodoky G, Barone C, Aranda E, Nordlinger B, Cisar L, Labianca R, Cunningham D, Van Cutsem E, Bosman F. Roth AD, et al. Among authors: bosman f. J Clin Oncol. 2010 Jan 20;28(3):466-74. doi: 10.1200/JCO.2009.23.3452. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008640 Clinical Trial.

3

[Endobrachioesophagus and adenocarcinoma: morphology and molecules].

Bosman F, Clément G, Renault S, Benhattar J. Bosman F, et al. Ann Pathol. 2006 Nov;26 Spec No 1:1S33-4. Ann Pathol. 2006. PMID: 17149171 French. No abstract available.

4

[Molecular pathology of colon cancer].

Bosman FT, Yan P. Bosman FT, et al. Pol J Pathol. 2014 Dec;65(4 Suppl 1):S1-11. Pol J Pathol. 2014. PMID: 26165028 Review. Polish. No abstract available.

5

Immunohistochemical localization of hTERT protein in human tissues.

Yan P, Benhattar J, Seelentag W, Stehle JC, Bosman FT. Yan P, et al. Histochem Cell Biol. 2004 May;121(5):391-7. doi: 10.1007/s00418-004-0645-5. Epub 2004 May 7. Histochem Cell Biol. 2004. PMID: 15138842

6

Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial.

Bosman FT, Yan P, Tejpar S, Fiocca R, Van Cutsem E, Kennedy RD, Dietrich D, Roth A. Bosman FT, et al. Clin Cancer Res. 2009 Sep 1;15(17):5528-33. doi: 10.1158/1078-0432.CCR-09-0741. Epub 2009 Aug 18. Clin Cancer Res. 2009. PMID: 19690194 Free article. Clinical Trial.

7

Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter.

Renaud S, Bosman FT, Benhattar J. Renaud S, et al. Biochem Biophys Res Commun. 2003 Jan 3;300(1):47-54. doi: 10.1016/s0006-291x(02)02775-4. Biochem Biophys Res Commun. 2003. PMID: 12480519

8

An agarose matrix facilitates sectioning of tissue microarray blocks.

Yan P, Seelentag W, Bachmann A, Bosman FT. Yan P, et al. J Histochem Cytochem. 2007 Jan;55(1):21-4. doi: 10.1369/jhc.6A6987.2006. Epub 2006 Aug 9. J Histochem Cytochem. 2007. PMID: 16899763

9

PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.

Bougel S, Renaud S, Braunschweig R, Loukinov D, Morse HC 3rd, Bosman FT, Lobanenkov V, Benhattar J. Bougel S, et al. J Pathol. 2010 Jan;220(1):87-96. doi: 10.1002/path.2620. J Pathol. 2010. PMID: 19806612 Free PMC article.

10

Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial.

Tejpar S, Yan P, Piessevaux H, Dietrich D, Brauchli P, Klingbiel D, Fiocca R, Delorenzi M, Bosman F, Roth AD. Tejpar S, et al. Among authors: bosman f. Eur J Cancer. 2018 Aug;99:66-77. doi: 10.1016/j.ejca.2018.05.009. Epub 2018 Jun 14. Eur J Cancer. 2018. PMID: 29909091 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters